Pyo Jung-Soo, Jung Jaehag, Lee Seul Gi, Kim Nae-Yu, Kang Dong-Wook
Department of Pathology, Daejeon Eulji University Hospital, Eulji University School of Medicine, Daejeon 35233, Korea.
Department of Surgery, Daejeon Eulji University Hospital, Eulji University School of Medicine, Daejeon 35233, Korea.
Diagnostics (Basel). 2020 Sep 18;10(9):717. doi: 10.3390/diagnostics10090717.
The present study aims to evaluate the diagnostic accuracy between ultrasonography-guided fine-needle aspiration cytology (US-FNAC) and core needle biopsy (CNB) of axillary lymph nodes (ALNs) in patients with breast cancer through a meta-analysis and a diagnostic test accuracy (DTA) review.
The present meta-analysis and DTA review included 67 eligible studies. The diagnostic accuracy of various preoperative assessments, including US-FNAC and CNB, was evaluated for ALNs assessments in patients with breast cancer. In addition, a subgroup analysis based on methods of cytologic preparation was performed. In the DTA review, the sensitivity, specificity, diagnostic odds ratio (OR) and area under the curve (AUC) on the summary receiver operating characteristic (SROC) curve were calculated.
The diagnostic accuracy of the preoperative assessments of ALNs was 0.850 (95% confidence interval (CI) 0.833-0.866) for patients with breast cancer. The diagnostic accuracy of CNB was significantly higher than that of US-FNAC (0.896, 95% CI 0.844-0.932 vs. 0.844, 95% CI 0.825-0.862; = 0.044 in a meta-regression test). In the subgroup analysis based on cytologic preparation, the diagnosis accuracies were 0.860, 0.861 and 0.859 for the methods of conventional smear, liquid-based preparation and cell block, respectively. In the DTA review, CNB showed higher sensitivity than US-FNAC (0.849 vs. 0.760). However, there was no difference in specificity between US-FNAC and CNB (0.997 vs. 1.000). US-FNAC with liquid-based preparation and CNB showed the highest diagnostic OR and AUC on the SROC, respectively.
Both US-FNAC and CNB are useful in preoperative assessments of ALNs in patients with breast cancer. Although the most sensitive test was found to be CNB in this study, there was no difference in specificity between various preoperative evaluations and the application of US-FNAC or CNB may be impacted by various factors.
本研究旨在通过荟萃分析和诊断试验准确性(DTA)综述,评估超声引导下细针穿刺细胞学检查(US-FNAC)和粗针穿刺活检(CNB)对乳腺癌患者腋窝淋巴结(ALN)的诊断准确性。
本荟萃分析和DTA综述纳入了67项符合条件的研究。评估了包括US-FNAC和CNB在内的各种术前评估对乳腺癌患者ALN评估的诊断准确性。此外,基于细胞学标本制备方法进行了亚组分析。在DTA综述中,计算了汇总受试者工作特征(SROC)曲线上的敏感性、特异性、诊断比值比(OR)和曲线下面积(AUC)。
乳腺癌患者ALN术前评估的诊断准确性为0.850(95%置信区间[CI] 0.833 - 0.866)。CNB的诊断准确性显著高于US-FNAC(0.896,95% CI 0.844 - 0.932对0.844,95% CI 0.825 - 0.862;在荟萃回归检验中P = 0.044)。在基于细胞学标本制备的亚组分析中,传统涂片、液基制片和细胞块方法的诊断准确性分别为0.860、0.861和0.859。在DTA综述中,CNB显示出比US-FNAC更高的敏感性(0.849对0.760)。然而,US-FNAC和CNB之间的特异性没有差异(0.997对1.000)。液基制片的US-FNAC和CNB在SROC上分别显示出最高的诊断OR和AUC。
US-FNAC和CNB在乳腺癌患者ALN的术前评估中均有用。尽管本研究中发现最敏感的检查是CNB,但各种术前评估之间的特异性没有差异,US-FNAC或CNB的应用可能受到多种因素的影响。